Original Research Article
Year: 2019 | Month: October | Volume: 6 | Issue: 10 | Pages: 252-258
To Study the Safety and Efficacy of Post-Partum Intra-Uterine Contraceptive Device
Lt Col Bidhan Roy1, Shivakumar R N2, M M Paprikar3
1Classified Specialist (Obstetrics & Gynaecology) & Gynae Oncology, Army Hospital (Research & Referral)
2Classified Specialist (Obstetrics & Gynaecology), Military Hospital, Mathura, India
3Classified Specialist (Obstetrics & Gynaecology), Indian Naval Hospital Kalyani, Vishakhapattnam, India
Corresponding Author: Lt Col Bidhan Roy
ABSTRACT
Background: Post-partum intra-uterine contraceptive device provides a safe and an ideal contraceptive choice that can be effectively implemented by optimizing the available hospital resources. Proactive advocacy of post-partum contraception has many fold health benefits and averts complications of unwanted pregnancies.
Methods: It is a prospective cohort study to assess the safety, efficacy, failure rate and feasibility of post-partum application of Cu-T 380 A in our service hospitals. After adequate counseling and valid consent; 150 patients were included in the study group. Amongst them; 27 % as intra-caesarean, 30% as immediate post placental and 43% within 48 hours post normal delivery were provided with post-partum Copper T 380 A.
Results: During the follow-up period; 12 % reported with bleeding per vaginum, 10% cited abdominal discomfort and 5% complained of discharge per vaginum. All these problems were managed conservatively without any complications. There was no history of any pregnancy in our study. Removal rate figured upto 13% including the expulsion rate of 4%. At the end of the study duration of 24 months; approximately 87% patients were found to satisfactorily continue PPIUCD.
Conclusion: Post-partum intra-uterine contraceptive device provides a safe, reversible and effective contraceptive method for our clientele.
Key words: Post-partum, Copper T 380 A
[PDF Full Text]